Diagnostic and prognostic markers in sepsis

被引:7
作者
Vincent, Jean-Louis [1 ]
Beumier, Marjorie [1 ]
机构
[1] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, B-1070 Brussels, Belgium
关键词
biomarkers; C-reactive protein; procalcitonin; sepsis; C-REACTIVE PROTEIN; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; WAVE-FORM ANALYSIS; PLASMINOGEN-ACTIVATOR RECEPTOR; RESPIRATORY-TRACT INFECTIONS; COMMUNITY-ACQUIRED PNEUMONIA; NEUTROPHIL CD64 EXPRESSION; ANTIGEN-DR EXPRESSION; GOAL-DIRECTED THERAPY;
D O I
10.1586/ERI.13.9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Sepsis is a common and serious complication in intensive care unit patients. An important factor in optimizing survival rates in septic patients is the ability to start treatment early in the course of disease; there is, therefore, a need for accurate diagnostic tests. In recent years, there has been a move away from the rather vague and nonspecific signs that were previously used to diagnose sepsis towards the possible adjunctive role of biomarkers. Many biomarkers have been proposed and assessed clinically, but none alone is specific enough to definitively determine diagnosis. The future direction of research is most likely a greater focus on the use of panels or combinations of markers with clinical signs. Some biomarkers may also be useful for prognosis and guiding therapy. Here, the authors will review our changing approaches to sepsis diagnosis and discuss some of the markers that seem most relevant at the present time.
引用
收藏
页码:265 / 275
页数:11
相关论文
共 109 条
  • [1] Aikawa Naoki, 2005, Journal of Infection and Chemotherapy, V11, P152, DOI 10.1007/s10156-005-0388-9
  • [2] A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis
    Andaluz-Ojeda, David
    Bobillo, Felipe
    Iglesias, Veronica
    Almansa, Raquel
    Rico, Lucia
    Gandia, Francisco
    Resino, Salvador
    Tamayo, Eduardo
    Ortiz de Lejarazu, Raul
    Bermejo-Martin, Jesus F.
    [J]. CYTOKINE, 2012, 57 (03) : 332 - 336
  • [3] Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review
    Backes, Yara
    van der Sluijs, Koenraad F.
    Mackie, David P.
    Tacke, Frank
    Koch, Alexander
    Tenhunen, Jyrki J.
    Schultz, Marcus J.
    [J]. INTENSIVE CARE MEDICINE, 2012, 38 (09) : 1418 - 1428
  • [4] Barie Philip S, 2004, Surg Infect (Larchmt), V5, P145, DOI 10.1089/sur.2004.5.145
  • [5] Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients
    Bele, Nicolas
    Darmon, Michael
    Coquet, Isaline
    Feugeas, Jean-Paul
    Legriel, Stephane
    Adaoui, Nadir
    Schlemmer, Benoit
    Azoulay, Elie
    [J]. BMC INFECTIOUS DISEASES, 2011, 11
  • [6] Hematologic profile of sepsis in neonates: Neutrophil CD64 as a diagnostic marker
    Bhandari, Vineet
    Wang, Chao
    Rinder, Christine
    Rinder, Henry
    [J]. PEDIATRICS, 2008, 121 (01) : 129 - 134
  • [7] Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study
    Blanco, Jesus
    Muriel-Bombin, Arturo
    Sagredo, Victor
    Taboada, Francisco
    Gandia, Francisco
    Tamayo, Luis
    Collado, Javier
    Garcia-Labattut, Angel
    Carriedo, Demetrio
    Valledor, Manuel
    De Frutos, Martin
    Lopez, Maria-Jesus
    Caballero, Ana
    Guerra, Jose
    Alvarez, Braulio
    Mayo, Agustin
    Villar, Jesus
    [J]. CRITICAL CARE, 2008, 12 (06)
  • [8] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [9] SEPSIS SYNDROME - A VALID CLINICAL ENTITY
    BONE, RC
    FISHER, CJ
    CLEMMER, TP
    SLOTMAN, GJ
    METZ, CA
    BALK, RA
    [J]. CRITICAL CARE MEDICINE, 1989, 17 (05) : 389 - 393
  • [10] Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis
    Borgel, D
    Clauser, S
    Bornstain, C
    Bièche, I
    Bissery, A
    Remones, V
    Fagon, JY
    Aiach, M
    Diehl, JL
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (01) : 219 - 222